TY  - JOUR
AU  - Hontecillas-Prieto, Lourdes
AU  - Garcia-Dominguez, Daniel J
AU  - Vaca, Diego Pascual
AU  - Garcia-Mejias, Rosa
AU  - Marcilla, David
AU  - Ramirez-Villar, Gema L
AU  - Saez, Carmen
AU  - de Álava, Enrique
PY  - 2017
DO  - 10.18632/oncotarget.14491
UR  - http://hdl.handle.net/10668/10746
T2  - Oncotarget
AB  - Wilms tumour (WT) is the most common renal tumour in children. Most WT patients respond to chemotherapy, but subsets of tumours develop resistance to chemotherapeutic agents, which is a major obstacle in their successful treatment. Multidrug...
LA  - en
KW  - MDR3
KW  - MRP1
KW  - Wilms tumours
KW  - blastemal stratification
KW  - multidrug resistance transporters
KW  - ATP Binding Cassette Transporter, Subfamily B
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - Child
KW  - Child, Preschool
KW  - Dactinomycin
KW  - Drug Resistance, Multiple
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Immunoblotting
KW  - Immunohistochemistry
KW  - Infant
KW  - Kidney Neoplasms
KW  - Membrane Transport Proteins
KW  - Multidrug Resistance-Associated Proteins
KW  - Nephrectomy
KW  - Outcome Assessment, Health Care
KW  - Prognosis
KW  - Retrospective Studies
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Tissue Array Analysis
KW  - Vincristine
KW  - Wilms Tumor
TI  - Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
TY  - research article
VL  - 8
ER  -